Delivery Order SPE2DR25D2206-SPE2DR26F9AE7
- Not listed
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on July 14, 2025, with performance completion by July 15, 2025. This non-set-aside, firm fixed price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger vehicle supporting the federal medical supply chain. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,800.84 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on October 31, 2025, with an ultimate completion date of November 3, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency has awarded a delivery order valued at $8,701.23 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $2,763.00 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,990.37 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/ml vials. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply transaction. The award represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes with a ceiling value of $17,402.52. This firm fixed price delivery order, which carries an ultimate completion date of November 6, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,381.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Pegasys 180 mcg/mL vials. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AE7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,502.05 to AmerisourceBergen Drug Corp for Pegasys 180 micrograms per 0.5 milliliter syringes. This competitively awarded, firm fixed-price delivery order was issued on November 5, 2025, with an ultimate completion date of November 6, 2025. The pharmaceutical product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is registered in the System for Award Management and serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capabilities in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a non-set-aside award, this delivery order reflects the vendor's competitive standing among pharmaceutical suppliers supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 11/5/25 |